ADI vs LAB · P/E 61, rev $11.02B vs rev $174.4M
Analog Devices Inc (ADI) versus Standard Biotools Inc (LAB) — a side-by-side from cached financials, not a winner call.
Analog Devices Inc (ADI) is a semiconductors company listed on NASDAQ.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
Latest reported ADI revenue for 2025-11-01 was $11.02B. Net income was $2.27B. ADI currently screens at market cap $201.87B and trailing P/E 61.5.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
ADI currently screens at market cap $201.87B and trailing P/E 61.5. LAB currently screens at market cap $317.1M.
Not investment advice. Open the ADI and LAB stock pages for the full models.
Not investment advice.